During the past decade, University of Connecticut conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Connecticut" #1 collaborator was "Huntington Study Group" with 1 trials as a collaborator, "National Human Genome Research Institute (NHGRI)" with 1 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Connecticut" are "Huntington Disease" (2 trials). Many other conditions were trialed in "University of Connecticut" in a lesser frequency.

The vast majority of trials in "University of Connecticut" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Connecticut". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University of Connecticut, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Connecticut, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".